AI-generated summary
The authors retrospectively reviewed 73 patients with meibomian gland dysfunction who received at least three intense pulsed light treatments and were followed for over 3 months. Patients were classed as responsive or nonresponsive based on symptom and meibum improvement. Nonresponders showed more gland dropout, extreme thinning and poor upper meibum quality before treatment, which the authors report was associated with resistance to IPL.
- Participants
- 73
- Who or what was studied
- Patients with meibomian gland dysfunction who received at least three IPL treatments between January 2022 and December 2023
- Limits stated in the abstract
- The study was retrospective and included only 15 nonresponsive patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on nature.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.